Bayer (BAYN GY) announce that they remain confident in Asundexian's potential, adding that it's too early to comment on specific sales numbers
Importance
Level 1
#GERMANY#EUROPE#BAYER AG#BAYN.GY#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BAYN#EURO STOXX 50#DAX 40 INDEX